Evaluation of economic efficiencies in clinical retina practice: Activity-based cost analysis and modeling to determine impacts of changes in patient management

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 913-925

  Murray, Timothy G ^a   Tornambe, Paul ^b   Dugel, Pravin ^c   Tong, Kuo Bianchini ^d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Tornambe Eye Institute   (United States)

^c RETINAL CONSULTANTS OF ARIZONA   (United States)

^d Quorum Consulting   (United States)

Author keywords

Activity based cost analysis; Practice utilization; Pro forma modeling; Retinal practice

Indexed keywords

ARTICLE; CHANGE MANAGEMENT; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HOSPITAL MANAGEMENT; HUMAN; INJECTION; LASER SURGERY; MATHEMATICAL MODEL; MEDICAL SPECIALIST; OPTICAL COHERENCE TOMOGRAPHY; PROFIT; REIMBURSEMENT; RETINA; RETROSPECTIVE STUDY; TREND STUDY; VITRECTOMY;

EID: 79960391212     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/opth.s22019     Document Type: Article

References (24)

1. Wagner AK, Graves AJ, Reiss SK, Lecates R, Zhang F, Ross-Degnan D. Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. Health Policy. 2011;100(2-3):151-158.
2. Erlyana E, Damrongplasit KK, Melnick G. Expanding health insurance to increase health care utilization: will it have different effects in rural vs urban areas? Health Policy. 2011;100(2-3):273-281.
3. Sinaiko AD, Rosenthal MB. Increased price transparency in health care-challenges and potential effects. N Engl J Med. 2011;364(10): 891-894.
4. Dugel PU, Tong KB. Development of an activity-based costing model to evaluate physician office practice profitability. Ophthalmology. 2011;118(1):203-208.
5. Ginsburg PB. Rapidly evolving physician-payment policy-more than the SGR. N Engl J Med. 2011;364(2):172-176.
6. Ginsburg PB. Wide variation in hospital and physician payment rates evidence of provider market power. Res Briefs. 2010;16:1-11.
7. Cooper R, Kramer TR. Revenue-based cost assignment: a potent but hidden threat to the survival of the multispecialty medical practice. Acad Med. 2010;85(3):538-547.
8. Cooper R, Kramer TR. Revenue-based cost assignment: the hidden and inaccurate equal-profit-margin assumption. MGMA Connex. 2008;8: 44-47.
9. Cooper R, Kramer TR. RBRVS costing: the inaccurate wolf in expensive sheep's clothing. J Health Care Finance. 2008;34(3):6-18.
10. Grandlich C. Using activity-based costing in surgery. AORN J. 2004; 79(1):189-192.
11. Lievens Y, van den Bogaert W, Kesteloot K. Activity-based costing: a practical model for cost calculation in radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57(2):522-535.
12. Emmett D, Forget R. The utilization of activity-based cost accounting in hospitals. J Hosp Mark Public Relations. 2005;15(2):79-89.
13. Cao P, Toyabe S, Kurashima S, Okada M, Akazawa K. A modified method of activity-based costing for objectively reducing cost drivers in hospitals. Methods Inf Med. 2006;45(4):462-469.
14. Sturzlinger H, Genser D, Froschl B. Evaluation of optical coherence tomography in the diagnosis of age related macula degeneration compared with fluorescence angiography. GMS Health Technol Assess. 2007;3:Doc02.
15. Patel JJ, Mendes MA, Bounthavong M, Christopher ML, Boggie D, Morreale AP. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model. J Eval Clin Pract. September 16, 2010. [Epub ahead of print].
16. Myung JS, Bhatnagar P, Spaide RF, et al. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina. 2010;30(5):748-755.
17. Spaide RF. The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system. Am J Ophthalmol. 2009;148(1):1-3.
18. Brown G, Brown MM. Let us wake the nation on the treatment for age-related macular degeneration. Curr Opin Ophthalmol. 2010; 21(3):169-171.
19. Brown MM, Luo B, Brown HC, Brown GC. Comparative effectiveness: its role in the healthcare system. Curr Opin Ophthalmol. 2009; 20(3):188-194.
20. Shipman SA, Lan J, Chang CH, Goodman DC. Geographic maldistribution of primary care for children. Pediatrics. 2011;127(1):19-27.
21. Brown MM, Brown GC, Leiske HB, Lieske PA. Healthcare costs, buyer alert. Curr Opin Ophthalmol. 2011;22(3):149-151.
22. Cruess AF, Zlateva G, Xu X, et al. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study. Pharmacoeconomics. 2008;26(1):57-73.
23. Cruess A, Zlateva G, Xu X, Rochon S. Burden of illness of neovascular age-related macular degeneration in Canada. Can J Ophthalmol. 2007;42(6):836-843.
24. Cunningham PJ, Felland LE, Ginsburg PB, Pham HH. Qualitative methods: a crucial tool for understanding changes in health systems and health care delivery. Med Care Res Rev. 2011;68(1):34-40.